Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Bone Marrow Transplant for Dyskeratosis Congenita
Recruiting3 awardsPhase 2
Cincinnati, Ohio
This trial will test whether a bone marrow transplantation (BMT) can be successful without using DNA damaging agents, which can make the lung and liver disease and risk of cancer worse, in patients with dyskeratosis congenita (DC).
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.